DARK SECRETS: Bms | Rare Historical Photos

AstraZeneca should stick to its winning formula. It doesn’t need a $400bn US mega-merger

The Anglo-Swedish drugmaker’s flirtation with a grand combo with US group Bristol Myers Squibb is baffling

The Guardian - UK · Aug 3

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

IN FULL

The Independent UK · Aug 3

AstraZeneca share prices drop amid £300bn mega-merger talks with US rival

The merger would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company

The Independent UK · Aug 3

Bristol-Myers Squibb Stock Rises on Anthropic AI Deal. Why This Could Actually Be a Key Upside Catalyst.

BMY stock rose after the company announced a strategic AI deal with Anthropic to deploy Claude across its workforce.

Barchart · May 22

Braemar H2 Earnings Call Highlights

Braemar (LON:BMS) reported full-year revenue of £135.6 million for FY2026, down 4% from the prior year, as weaker chartering rates weighed on performance, particularly in the first half. The shipbroking and investment advisory group said underlying operating profit fell 21% to £13.2 million, while u

MarketBeat · May 21

BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM

BioNTech (NASDAQ:BNTX) used its virtual annual general meeting to outline a transition year marked by leadership changes, continued investment in oncology, a planned share repurchase program and a restructuring of its manufacturing network. Chairman of the Supervisory Board Helmut Jeggle said the 2

MarketBeat · May 15

Zero Battery Degradation: My Volvo PHEV Is Still Going Strong After 42,000 Miles

My “unicorn” Volvo V90 plug-in hybrid wagon is almost four years old. Here’s how healthy its high-voltage battery is.

InsideEVs · Jan 11

Bristol Myers Expands Cell Therapy Portfolio With Orbital Therapeutics Acquisition

Bristol Myers Squibb Co. (NYSE:BMY) on Friday agreed to acquire Orbital Therapeutics, a privately held biotechnology company focused on RNA medicines that reprogram the immune system in vivo.

Benzinga · Oct 10, 2025

NHS facing ‘critical threat’ after Trump pressure to hike drug prices

NEWS ANALYSIS: Drug prices in the UK could rise amid 100 per cent tariffs on branded medicines and pressure from US President Donald Trump to stop ‘global freeloading’, Alicja Hagopian reports

The Independent UK · Sep 26, 2025

Walmart shrimp laced with radioactive material, FDA warns public as it can damage DNA

But Americans' reactions have so far been unexpectedly lighthearted.

We Got This Covered · Aug 20, 2025